Plasma palmitoylethanolamide (PEA) as a potential biomarker for impaired coronary function
Published inInternational Journal of Cardiology, vol. 231, p. 1-5
Publication date2017
Abstract
Keywords
- Biomarkers/blood
- Body Mass Index
- Chromatography, Liquid
- Coronary Artery Disease/blood/diagnosis/etiology
- Coronary Circulation/physiology
- Coronary Vessels/diagnostic imaging/physiopathology
- Electrocardiography
- Enzyme-Linked Immunosorbent Assay
- Ethanolamines/blood
- Humans
- Obesity/blood/complications
- Palmitic Acids/blood
- Positron Emission Tomography Computed Tomography
- Regional Blood Flow/physiology
- Vasoconstriction/physiology
Citation (ISO format)
QUERCIOLI, Alessandra et al. Plasma palmitoylethanolamide (PEA) as a potential biomarker for impaired coronary function. In: International Journal of Cardiology, 2017, vol. 231, p. 1–5. doi: 10.1016/j.ijcard.2016.12.023
Main files (1)
Article (Published version)

Identifiers
- PID : unige:112122
- DOI : 10.1016/j.ijcard.2016.12.023
- PMID : 27989579
ISSN of the journal0167-5273